ArriVent BioPharma, Inc. Common Stock Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.64 | -$0.64 | -$0.64 |
| Q2 2024 | 1 | -$1.00 | -$1.00 | -$1.00 |
| Q3 2024 | 4 | -$1.15 | -$0.65 | -$0.80 |
| Q1 2025 | 2 | -$0.79 | -$0.79 | -$0.79 |
| Q2 2025 | 1 | -$0.86 | -$0.86 | -$0.86 |
| Q3 2025 | 1 | -$0.86 | -$0.86 | -$0.86 |
| Q4 2025 | 1 | -$0.95 | -$0.95 | -$0.95 |
ArriVent BioPharma, Inc. Common Stock Earnings Date And Information
ArriVent BioPharma, Inc. Common Stock last posted its earnings results on Wednesday, August 14th, 2024. The company reported $-0.65 earnings per share for the quarter, missing analysts' consensus estimates of $-0.65 by $0. The company had revenue of 0 for the quarter and had revenue of 0 for the year. ArriVent BioPharma, Inc. Common Stock has generated $-2 earnings per share over the last year ($-2.17 diluted earnings per share) and currently has a price-to-earnings ratio of -12.1. ArriVent BioPharma, Inc. Common Stock has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 13th, 2024 based on prior year's report dates.
ArriVent BioPharma, Inc. Common Stock Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 06/28/2024 | Q2 2024 | -$0.65 | $1.33 M | $0 | ||
| 03/30/2024 | Q1 2024 | -$0.52 | $0 | |||
| 12/30/2023 | Q4 2023 | -$0.63 | $0 | |||
| 09/29/2023 | Q3 2023 | -$0.43 | $0 | |||
| 06/29/2023 | Q2 2023 | -$0.64 | $0 | |||
| 03/30/2023 | Q1 2023 | -$0.36 | $0 | |||
| 12/29/2022 | Q4 2022 | -$0.31 | $0 | |||
| 09/28/2022 | Q3 2022 | -$0.35 | $0 |
ArriVent BioPharma, Inc. Common Stock Earnings: Frequently Asked Questions
-
When is ArriVent BioPharma, Inc. Common Stock's earnings date?
ArriVent BioPharma, Inc. Common Stock has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 13th, 2024 based off last year's report dates.
-
How can I listen to ArriVent BioPharma, Inc. Common Stock's earnings conference call?
The conference call for ArriVent BioPharma, Inc. Common Stock's latest earnings report can be listened to online.
-
How can I read ArriVent BioPharma, Inc. Common Stock's conference call transcript?
The conference call transcript for ArriVent BioPharma, Inc. Common Stock's latest earnings report can be read online.
-
How much profit does ArriVent BioPharma, Inc. Common Stock generate each year?
ArriVent BioPharma, Inc. Common Stock (:AVBP) has a recorded net income of $0. ArriVent BioPharma, Inc. Common Stock has generated $-2.17 earnings per share over the last four quarters.
-
What is ArriVent BioPharma, Inc. Common Stock's price-to-earnings ratio?
ArriVent BioPharma, Inc. Common Stock (:AVBP) has a price-to-earnings ratio of -12.1 and price/earnings-to-growth ratio is 26.87.
